W. Kobinger

4.0k total citations
104 papers, 3.3k citations indexed

About

W. Kobinger is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, W. Kobinger has authored 104 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 40 papers in Cellular and Molecular Neuroscience and 22 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in W. Kobinger's work include Receptor Mechanisms and Signaling (35 papers), Pharmacological Receptor Mechanisms and Effects (17 papers) and Neuropeptides and Animal Physiology (16 papers). W. Kobinger is often cited by papers focused on Receptor Mechanisms and Signaling (35 papers), Pharmacological Receptor Mechanisms and Effects (17 papers) and Neuropeptides and Animal Physiology (16 papers). W. Kobinger collaborates with scholars based in Austria, Australia and Denmark. W. Kobinger's co-authors include Ludwig Pichler, A. Walland, Christian Lillie, W Hoefke, Oleh Hornykiewicz, Christian Pifl, G. Schingnitz, Rudolf Hammer, F Lund and O. Kraupp and has published in prestigious journals such as CHEST Journal, Journal of Medicinal Chemistry and European Heart Journal.

In The Last Decade

W. Kobinger

100 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Kobinger Austria 32 1.6k 1.5k 830 637 231 104 3.3k
S Z Langer France 25 2.0k 1.2× 2.0k 1.4× 461 0.6× 798 1.3× 176 0.8× 48 3.5k
Henri Schmitt France 27 1.3k 0.8× 1.1k 0.8× 538 0.6× 588 0.9× 135 0.6× 102 2.7k
E. Muscholl Germany 29 1.7k 1.0× 1.3k 0.9× 841 1.0× 673 1.1× 144 0.6× 161 3.2k
G.M. Drew United Kingdom 26 1.4k 0.9× 1.3k 0.9× 471 0.6× 882 1.4× 151 0.7× 75 2.9k
P. A. van Zwieten Netherlands 25 994 0.6× 712 0.5× 631 0.8× 551 0.9× 196 0.8× 109 2.2k
S. M. Kirpekar United States 30 1.7k 1.0× 1.3k 0.9× 408 0.5× 597 0.9× 83 0.4× 85 2.6k
L. Stjärne Sweden 35 2.2k 1.3× 2.1k 1.4× 467 0.6× 855 1.3× 197 0.9× 161 3.7k
Marlene L. Cohen United States 37 2.2k 1.4× 1.9k 1.3× 739 0.9× 1.3k 2.0× 189 0.8× 169 5.0k
Virginia K. Weise United States 30 851 0.5× 1.1k 0.8× 444 0.5× 846 1.3× 217 0.9× 75 3.3k
G. Hertting Germany 30 1.5k 0.9× 1.7k 1.2× 325 0.4× 517 0.8× 258 1.1× 136 3.3k

Countries citing papers authored by W. Kobinger

Since Specialization
Citations

This map shows the geographic impact of W. Kobinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Kobinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Kobinger more than expected).

Fields of papers citing papers by W. Kobinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Kobinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Kobinger. The network helps show where W. Kobinger may publish in the future.

Co-authorship network of co-authors of W. Kobinger

This figure shows the co-authorship network connecting the top 25 collaborators of W. Kobinger. A scholar is included among the top collaborators of W. Kobinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Kobinger. W. Kobinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lillie, Christian, et al.. (1988). Effects of alinidine on survival and infarct size in rats with coronary artery occlusion. European Journal of Pharmacology. 157(1). 75–81. 8 indexed citations
3.
Lillie, Christian & W. Kobinger. (1987). Investigations differentiating the mechanism of specific bradycardic agents from that of calcium channel blockers. Naunyn-Schmiedeberg s Archives of Pharmacology. 335(3). 331–3. 6 indexed citations
4.
Harron, Dean W.G., W. Kobinger, & Christian Lillie. (1984). Effects of peripheral α1- and α2-adrenoceptor agonists on baroreceptor responsiveness in conscious dogs. European Journal of Pharmacology. 104(1-2). 71–78. 2 indexed citations
5.
Kobinger, W.. (1984). New concepts on alpha-adrenoceptors in pharmacology.. PubMed. 15 Suppl 1. 5–22. 12 indexed citations
6.
Kobinger, W. & Ludwig Pichler. (1983). selectivity ratio in a series of agonists and their relation to pre/postsynaptic activity ratios. European Journal of Pharmacology. 91(1). 129–133. 11 indexed citations
7.
Lillie, Christian & W. Kobinger. (1983). Actions of Alinidine and AQ-A 39 on Rate and Contractility of Guinea Pig Atria During β-Adrenoceptor Stimulation. Journal of Cardiovascular Pharmacology. 5(6). 1048–1051. 6 indexed citations
8.
Kobinger, W. & Ludwig Pichler. (1981). α2-adrenoceptor agonistic effect of B-HT 920 in isolated perfused hindquarters of rats. European Journal of Pharmacology. 76(1). 101–105. 26 indexed citations
9.
Kobinger, W.. (1981). The Role of α-Adrenoceptors in Central Nervous and Peripheral Vascular Regulation. The Japanese Journal of Pharmacology. 31. 13–20. 4 indexed citations
10.
Pichler, Ludwig, P. Placheta, & W. Kobinger. (1980). Effect of azepexole (B-HT 933) on pre- and postsynaptic α-adrenoceptors at peripheral and central nervous sites. European Journal of Pharmacology. 65(2-3). 233–241. 24 indexed citations
11.
Lillie, Christian & W. Kobinger. (1978). [Pharmacologic differentiation between various anti-arrhythmics in animal experiments].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16. 3–16. 1 indexed citations
12.
Kobinger, W.. (1978). Central α-adrenergic systems as targets for hypotensive drugs. Reviews of physiology, biochemistry and pharmacology. 81. 39–100. 438 indexed citations
13.
Kobinger, W. & Ludwig Pichler. (1977). Pharmacological characterization of B-HT 933 (2-amino-6-ethyl-4,5,7,8-tetrahydro-6H-oxazolo-[5,4-d]-azepindihydrochloride) as a hypotensive agent of the ?Clonidine-type?. Naunyn-Schmiedeberg s Archives of Pharmacology. 300(1). 39–46. 65 indexed citations
14.
Kobinger, W. & Ludwig Pichler. (1976). Centrally induced reduction in sympathetic tone — A postsynaptic α-adrenoceptor-stimulating action of imidazolines. European Journal of Pharmacology. 40(2). 311–320. 89 indexed citations
15.
Walland, A., et al.. (1975). Proceedings: RA 642, a new pyrimidopyrimidine with central hypertensive properties.. PubMed. 287 Suppl. R23–R23. 2 indexed citations
16.
Walland, A., et al.. (1974). Action of clonidine on baroreceptor reflexes in conscious dogs. European Journal of Pharmacology. 26(2). 184–190. 23 indexed citations
17.
Kobinger, W.. (1967). [On the mechanism of action of a new antihypertensive substance with imidazoline structure].. PubMed. 258(1). 48–58. 27 indexed citations
18.
Lund, F & W. Kobinger. (1960). Aromatic Sulphamyl Compounds with Diuretic Action. Acta Pharmacologica et Toxicologica. 16(4). 297–324. 13 indexed citations
19.
Kobinger, W.. (1959). Zusammenhang zwischen experimenteller Katatonie und F�rderung von tonischen Streckkr�mpfen. Naunyn-Schmiedeberg s Archives of Pharmacology. 235(2). 87–95. 3 indexed citations
20.
Kobinger, W. & O. Kraupp. (1955). �ber die Wirkung von Eserin am d-Tubocurarin-gel�hmten Rattenzwerchfell in Gegenwart depolarisierender Muskelrelaxantien. Naunyn-Schmiedeberg s Archives of Pharmacology. 225(1-2). 107–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Z Langer Breakdown of academic impact, for papers by Henri Schmitt Breakdown of academic impact, for papers by E. Muscholl Breakdown of academic impact, for papers by G.M. Drew Breakdown of academic impact, for papers by P. A. van Zwieten Breakdown of academic impact, for papers by S. M. Kirpekar Breakdown of academic impact, for papers by L. Stjärne Breakdown of academic impact, for papers by Marlene L. Cohen Breakdown of academic impact, for papers by Virginia K. Weise Breakdown of academic impact, for papers by G. Hertting
Rankless by CCL
2026